Brent Fulton discusses private equity’s investments in hospitals and assesses the risks it presents to key stakeholders: private equity investors, debt investors, patients, and the government. He argues financial transparency regulation is needed so fraudulent transfer and bankruptcy laws can be enforced to reduce uncompensated risk being borne by patients and the government (ultimately taxpayers).| ProMarket
Melissa Newham reviews how investors can alter the incentives and behavior of pharmaceutical companies to reduce competition and consumer welfare through common ownership and “rollup” deals.| ProMarket
Over the last year, the United States government has demonstrated increased concern about private equity’s involvement in health care. Barak Richman and Richard Scheffler discuss why the government’s actions have not yet matched the energy of its words and how academics and policymakers must continue to investigate private equity’s influences as they devise policy to […]| ProMarket
ProMarket is the publication of the George J. Stigler Center for the Study of the Economy and the State at the University of Chicago Booth School of Business. ProMarket is an academic forum focused on topics of special interest capture, antitrust, political economy, and the future of capitalism. Economists have become increasingly technical and specialized, […]| ProMarket
Antipsychotic drugs treat psychosis, a collection of symptoms that affect your brain’s ability to tell what’s real and what isn’t. Learn more here.| Cleveland Clinic
